4Tong SYC, Peleg AY, Yoog J, etal. Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient[J]. Transplant Infect Dis, 2007,9 : 241-243.
5Alfonso D, Isabel M, Mercedes G, et al. Economic evaluation of vorieonazole versus caspofungin for the treatment of invasive as pergillosis in Spain[J]. Clin Drug Invest,2007,27 : 197-205.
6Wingard JR, Herbrecht R, Mauskopf J,et al. Resource use and cost of treatment with vorieonazole or conventional amphotericin B for invasive aspergillosis[J]. Transplant Infect Dis, 2007,9 : 182-188.
7Candoni A, Mestroni R, Darniani D, et al. Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies [J].Eur J Haematol, 2005,75 : 227-233.
8Gonzalez-Vicent M, Lassaletta A, Lopez-Pino MA, et al. Aspergillus " fungus ball" of the bladder after hematopoietic transplantation in a pediatric patient: successful treatment with intravesical voriconazole and surgery[J].Pediatr Trans plant, 2008,12 : 242-245.
9Mukherjee PK, Sheehan DJ, Hitchcock CA. Combination treatment of invasive fungal infections[J]. Clin Microbiol Rev, 2005, 18:163-194.
10Maertens J, Glasmacher A, Herbrecht R, et al. Multicenter, non comparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis[J].Cancer, 2006,107 :2888-2897.
